QNCX icon

Quince Therapeutics
QNCX

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$4
14% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
56% 1-yr QNCX win rate
13 Nov ‘25 20 days ago